
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 8.540 | 8.540 | 0.000 |
Shares | 91.290 | 91.290 | 0.000 |
Other | 0.170 | 0.170 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 18.851 | 25.481 |
Price to Book | 2.688 | 2.925 |
Price to Sales | 1.865 | 3.863 |
Price to Cash Flow | 15.821 | 17.381 |
Dividend Yield | 2.948 | 1.895 |
5 Years Earnings Growth | 5.114 | 5.647 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 99.130 | 95.707 |
Consumer Cyclical | 0.870 | 0.990 |
Number of long holdings: 39
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Humanwell Healthcare | CNE000000QW6 | 9.57 | 21.91 | +1.01% | |
Jiangsu Hengrui | CNE0000014W7 | 8.80 | 60.79 | -0.46% | |
Shenzhen Mindray Bio-Medical | CNE100003G67 | 7.72 | 234.11 | +1.57% | |
WuXi AppTec | CNE1000031K4 | 7.60 | 91.30 | +0.08% | |
Cr Sanjiu A | CNE0000011K8 | 4.63 | 31.69 | -0.32% | |
Nhwa Pharma A | CNE100000CG8 | 4.41 | 23.56 | -1.96% | |
Jointown Pharm | CNE100000W45 | 3.33 | 5.36 | -0.19% | |
Hangzhou Tigermed Consulting | CNE100001KV8 | 3.12 | 66.99 | +0.15% | |
Yunnan Baiyao A | CNE0000008X7 | 2.82 | 55.95 | -0.11% | |
Pacific Shuanglin Bio pharmacy | CNE000000F14 | 2.82 | 18.54 | +0.16% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Morgan Stanley Huaxin Multiple Fact | 596.51M | 13.29 | 0.74 | 2.83 | ||
MS Huaxin Resource Selected Mixed | 403.14M | 8.00 | -10.20 | 2.31 | ||
MS Huaxin Aggressive Growth Equity | 323.97M | 5.76 | -6.56 | 3.09 | ||
Huaxin Leading Advanced Stock | 310.03M | 6.62 | -5.69 | 5.60 | ||
Huaxin Excellent Growth Stock | 241.91M | 7.02 | -10.78 | 3.27 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review